iPS Academia Japan, Inc.

What's new

News room


License-Out 2016/02/10

License Agreement Has Been Entered with StemoniX, Inc.

We executed a non-exclusive license agreement with StemoniX, Inc. which provides a service of iPS cell-derived cells for research use, on the basic and improvement patents which we have been granted a sublicensing right from Kyoto University and from Osaka University respectively.

StemoniX, Inc.

Other 2016/02/04

Search Window Opened on the Page of Patent Portfolio

We just opened a search window on the page of Patent Portfolio for keyword retrieval. It has been made available to search our patent portfolio not only by category, but also by various keywords depending on the descriptions in bibliographic data pages (application No., publication No., inventor, applicant (assignee), title of invention, abstract, etc.), and it would be helpful for you to find available technologies from more than 100 patent families from our Patent Portfolio which is frequently updated. Please try it out and find the one you are looking for.

Management Information 2016/01/25

iPS Academia Japan, Inc. Has Become an Approved TLO

A business plan of iPS Academia Japan, Inc. for iPS cell technology transfer operations (TLO operations) has been authorized by both the Minister of Education, Culture, Sports, Science and Technology (MEXT) and the Minister of Economy, Trade and Industry (METI) under the TLO Law (Law No. 52, May 6, 1998) in Japan, and then we have become an approved TLO in January 22, 2016.

Other 2015/12/17

Our Office Closed Dec. 29 – Jan 3

Our office will be closed for winter holidays from Tuesday 29th December 2015 to Sunday 3rd January 2016.
Please understand that our earliest replay to any inquiries received during the above period will be made on or after Monday 4th January 2016.

We apologize for your inconvenience this may cause you during this period.

License-Out 2015/11/18

License Agreement Has Been Entered with Applied StemCell, Inc.

We executed a non-exclusive license agreement with Applied StemCell, Inc. which provides iPS cell derived cells and services for iPS cell generation, differentiation and gene modification for research use, on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

Applied StemCell, Inc.

Exhibition 2015/11/09

BIO-Europe2015 in Germany

We presented our exhibition in Japan Pavilion hosted by JETRO at “BIO-Europe2015” in Munich, Germany from November 2nd (Mon.) till November 4th (Fri.), 2015. We very much appreciate many meetings in Munich regarding our possible collaborations.

BIO-Europe2015-01 BioEurope2015-02

License-Out 2015/11/02

License Agreement Has Been Entered with Cartilize Incorporated

We executed a license agreement with Cartilize Incorporated which provides iPS cell-derived chondrocyte products for use in therapeutic applications and research purposes, the license allowing exclusive and non-exclusive rights, respectively, on the patents related to chondrocyte induction and those related to iPS cell technology, for all of which we have been granted a sublicensing right from Kyoto University.

Cartilize Incorporated

Exhibition 2015/10/19

BioJapan2015 in Yokohama

We very much appreciate your visits to our booth at “BioJapan2015” in Yokohama from October 14th (Wed) till October 16th (Fri), 2015. The exhibition was successfully finished.

BioJapan2015

License-Out 2015/10/01

License Agreement with Regenerative Medical Solutions

We executed a non-exclusive license agreement with Regenerative Medical Solutions which provides pancreatic cell products for research use, on the patents related to iPS cell technology which we have been granted a sublicensing right from Kyoto University.

Regenerative Medical Solutions

License-In 2015/09/18

License Agreement with Exploit Technologies Pte Ltd (ETPL), the commercialization arm of the Agency for Science, Technology and Research (A*STAR)

A non-exclusive license with a sublicensing right has been granted from ETPL, a leading TLO in Singapore, on 3 families of patents and patent applications of A*STAR relating to marked acceleration of iPSC generation (AJ129, 130, 131).

1 / 612345...Last »